Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1280)	1/8/1998 8:50:00 PM
From: David S.	Respond to of 2205

yeah yeah yeah. Fundamentally, some biotech stocks are better shorts after products get fda approval, I am not short atis now, but depending on what happens after approval, may be.

To: Marshall Teitelbaum who wrote (1280)	1/9/1998 8:11:00 AM
From: Paul Shield	Read Replies (1) \| Respond to of 2205

Marshall, You're right. Implying your investing skills are poor was unwarrented. My apology. I just got irritated at your doing the very thing that you had just criticized. You implied that ORG product was more expensive than ATIS. That is an opinion. What would be helpful to all of us is to try to estimate costs, given the info that is available to us. If you do that for ATIS, I'll do it for ORG. Then maybe we have some basis to compare. The other opinions you offered were not balanced by the info that had already been posted. It wasn't your usual evenhanded approach and it irritated me. I thought you knew more than you were saying, leaving a biased statement.